• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

China stroke surveillance report 2021
AbstractSince 2015, stroke has become the leading cause of death and disability in China, posing a significant threat to the health of its citizens as a major chronic non-communicable disease. According to the China Stroke High-risk Population Screening and Intervention Program, an estimated 17.8 million [95% confidence interval (CI) 17.6 –18.0 million] adults in China had experienced a stroke in 2020, with 3.4 million (95% CI 3.3–3.5 million) experiencing their first-ever stroke and another 2.3 million (95% CI 2.2–2.4 million) dying as a result. Additionally, approximately 12.5% (95% CI 12.4–12.5%) of stroke survi...
Source: Military Medical Research - July 19, 2023 Category: International Medicine & Public Health Source Type: research

Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus
Front Med (Lausanne). 2022 Aug 23;9:995993. doi: 10.3389/fmed.2022.995993. eCollection 2022.ABSTRACTImmune dysfunction is widely regarded as one of the central tenants underpinning the pathophysiology of diabetes mellitus (DM) and its complications. When discussing immunity, the role of neutrophils must be accounted for: neutrophils are the most abundant of the circulating immune cells and are the first to be recruited to sites of inflammation, where they contribute to host defense via phagocytosis, degranulation, and extrusion of neutrophil extracellular traps (NETs). NETs are composed of DNA associated with nuclear and c...
Source: Atherosclerosis - September 9, 2022 Category: Cardiology Authors: Areez Shafqat Saleha Abdul Rab Osama Ammar Sulaiman Al Salameh Anas Alkhudairi Junaid Kashir Khaled Alkattan Ahmed Yaqinuddin Source Type: research

The Use of Embolic Protection Devices During Transcatheter Aortic Valve Implantation.
Authors: Shiyovich A, Kornowski R Abstract BACKGROUND: Aortic stenosis (AS) is a common valvular pathology and is increasing in prevalence. Severe symptomatic AS is associated with serious outcomes if left untreated. Transcatheter aortic valve implantation (TAVI) is an innovative modality, which has revolutionized the treatment of AS. With growing experience and technological upgrades, TAVI has become a valid alternative to surgical valve replacement. However, TAVI is associates with increase non-negligible risks of mortality, stroke, physical disability, and healthcare expenditures. Furthermore, imaging modalities...
Source: The Israel Medical Association Journal - September 24, 2019 Category: General Medicine Tags: Isr Med Assoc J Source Type: research

Abstract 205: Stroke Risk and Symptom Recognition Post Cardiac Catheterization Session Title: Poster Session PM
Over 1.4 million cardiac catheterization procedures (CCPs) take place yearly. CPP related stroke incidence in 1973 was reported as 0.23%. CCPs are invasive in nature with complications occurring due to unintentional trauma to preexisting atherosclerotic aortic plaques or thrombus formation at catheter/guidewire tips. Less common causes of ischemic stroke are air, left ventricular clot, hypotension, arterial dissection, fractured guidewire. Transient neurological deficits have been reported following high-osmolar contrast injection into carotid/vertebral arteries. With improved practice, current stroke incidence is 0.06%. P...
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Rivet, C., Schaefer, K., Strom, C. Tags: Session Title: Poster Session PM Source Type: research

Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base
Pulmonary embolism (PE) remains a worldwide major public health issue [1 –4]. After myocardial infarction and stroke, PE is the third most common cause of vascular death. In addition, PE is the leading preventable cause of death in hospitalized patients [2]. Treatment of PE costs over 19 billion dollars annually in the USA [3], and more than 50% of that expenditure rel ates to the cost of in-patient care [4]. The initial decision to admit the patient diagnosed with acute symptomatic PE in the emergency department (ED) to the hospital or to treat the patient at home therefore has significant patient care and public health implications.
Source: Thrombosis Research - November 25, 2017 Category: Hematology Authors: David Jim énez, Roger D. Yusen Tags: Editorial Source Type: research

Impact On Italian National Health Service Expenditure For The Treatment Of Venous Thromboembolism With Rivaroxaban
This study aims to evaluate the economic impact of the use of rivaroxaban for preventing DVT and PE in Italy.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Roggeri, DP Roggeri, V Pengo Source Type: research